C

Contineum Therapeutics Inc
NASDAQ:CTNM

Watchlist Manager
Contineum Therapeutics Inc
NASDAQ:CTNM
Watchlist
Price: 12.41 USD -2.13% Market Closed
Market Cap: 362.1m USD

Intrinsic Value

The intrinsic value of one CTNM stock under the Base Case scenario is hidden USD. Compared to the current market price of 12.41 USD, Contineum Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTNM Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Contineum Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

CTNM looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether CTNM usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CTNM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CTNM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Contineum Therapeutics Inc.

Explain Valuation
Compare CTNM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CTNM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Contineum Therapeutics Inc

Balance Sheet Decomposition
Contineum Therapeutics Inc

Current Assets 206.4m
Cash & Short-Term Investments 204.8m
Other Current Assets 1.6m
Non-Current Assets 6.5m
PP&E 6.5m
Other Non-Current Assets 3k
Current Liabilities 10m
Accounts Payable 1.8m
Accrued Liabilities 8.2m
Non-Current Liabilities 4.8m
Other Non-Current Liabilities 4.8m
Efficiency

Free Cash Flow Analysis
Contineum Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Contineum Therapeutics Inc

Revenue
0 USD
Operating Expenses
-50.9m USD
Operating Income
-50.9m USD
Other Expenses
8.6m USD
Net Income
-42.3m USD
Fundamental Scores

CTNM Profitability Score
Profitability Due Diligence

Contineum Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
hidden
Profitability
Score

Contineum Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CTNM Solvency Score
Solvency Due Diligence

Contineum Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Contineum Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTNM Price Targets Summary
Contineum Therapeutics Inc

Wall Street analysts forecast CTNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTNM is 22.44 USD with a low forecast of 14.14 USD and a high forecast of 30.45 USD.

Lowest
Price Target
14.14 USD
14% Upside
Average
Price Target
22.44 USD
81% Upside
Highest
Price Target
30.45 USD
145% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Contineum Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTNM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CTNM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CTNM stock?

The intrinsic value of one CTNM stock under the Base Case scenario is hidden USD.

Is CTNM stock undervalued or overvalued?

Compared to the current market price of 12.41 USD, Contineum Therapeutics Inc is hidden .

Back to Top